Peptide therapeutics

Peptide therapeutics


Peptide therapeutics are biologically active compounds or pharmaceuticals with peptide-based structures. They play a crucial role in various therapeutic areas, including the treatment of metabolic disorders, diabetes, cancer, and cardiovascular conditions. Their popularity is growing rapidly due to their established pharmacological effectiveness and strong safety profiles. The peptide therapeutics molecules market is expanding swiftly, fueled by the rising incidence of chronic diseases, technological advancements in peptide synthesis, and the growing demand for personalized medicine.

Catalog Product Name Structure M.W. Purity Pricing
Cancer
BP-50363LSKL, Inhibitor of Thrombospondin (TSP-1)Molecular structure of the compound: LSKL, Inhibitor of Thrombospondin (TSP-1)458.6Pricing
BP-503825-FAM-Pro-Leu-OHMolecular structure of the compound: 5-FAM-Pro-Leu-OH586.6Pricing
BP-50333NGR peptide, TFA saltMolecular structure of the compound: NGR peptide, TFA salt608.7Pricing
BP-50323MMP Colorimetric SubstrateMolecular structure of the compound: MMP Colorimetric Substrate655.9Pricing
BP-50336Ac-YVAD-pNAMolecular structure of the compound: Ac-YVAD-pNA628.6Pricing
BP-50330Ac-Ile-Glu-Thr-Asp-pNAMolecular structure of the compound: Ac-Ile-Glu-Thr-Asp-pNA638.6Pricing
BP-50320Ac-LEHD-pNAMolecular structure of the compound: Ac-LEHD-pNA674.7Pricing
BP-50398390 MMP FRET Substrate 5Molecular structure of the compound: 390 MMP FRET Substrate 51195.2Pricing
BP-50325Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2Molecular structure of the compound: Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH21100.2Pricing
BP-50349Suc-LLVY-AMCMolecular structure of the compound: Suc-LLVY-AMC763.9Pricing
BP-50319Ac-LEHD-AFCMolecular structure of the compound: Ac-LEHD-AFC765.7Pricing
BP-50329Ac-DEVD-AFCMolecular structure of the compound: Ac-DEVD-AFC729.6Pricing
BP-50331Ac-IETD-AFCMolecular structure of the compound: Ac-IETD-AFC729.7Pricing
BP-50327Z-DEVD-AFCMolecular structure of the compound: Z-DEVD-AFC821.7Pricing
BP-50332Ac-WEHD-AFCMolecular structure of the compound: Ac-WEHD-AFC838.8Pricing
BP-50367ATWLPPR PeptideMolecular structure of the compound: ATWLPPR Peptide840Pricing
BP-50388Shepherdin (79-87)Molecular structure of the compound: Shepherdin (79-87)949.1Pricing
BP-50369bFGF (119-126)Molecular structure of the compound: bFGF (119-126)993.2Pricing
BP-50345Enhanced Green Fluorescent Protein (EGFP) (200-208)Molecular structure of the compound: Enhanced Green Fluorescent Protein (EGFP) (200-208)1019.1Pricing
BP-50366GP100 (209–217)Molecular structure of the compound: GP100 (209–217)1005.1Pricing
BP-50334BA 1Molecular structure of the compound: BA 11133.3Pricing
BP-50335TNO211Molecular structure of the compound: TNO2111325.6Pricing
BP-50343Kisspeptin-10 (mouse, rat)Molecular structure of the compound: Kisspeptin-10 (mouse, rat)1318.5Pricing
BP-50340Human PD-L1 inhibitor VMolecular structure of the compound: Human PD-L1 inhibitor V1485.7Pricing
BP-50344Tyrosinase-related Protein 2 (TRP-2) (181-188)Molecular structure of the compound: Tyrosinase-related Protein 2 (TRP-2) (181-188)1088.3Pricing
BP-50368mTRP-2 (180-188)Molecular structure of the compound: mTRP-2 (180-188)1175.4Pricing
BP-50347Gp100 (25-33), mouseMolecular structure of the compound: Gp100 (25-33), mouse1104.2Pricing
BP-50350Kisspeptin-10, humanMolecular structure of the compound: Kisspeptin-10, human1302.5Pricing
BP-50360MART-1 (27-35) (human)Molecular structure of the compound: MART-1 (27-35) (human)814Pricing
BP-50372MART-1 (26-35) (human)Molecular structure of the compound: MART-1 (26-35) (human)943.1Pricing
BP-50362[Leu27]-Melan-A, MART-1 (26-35)Molecular structure of the compound: [Leu27]-Melan-A, MART-1 (26-35)985.2Pricing
BP-50321c-Myc PeptideMolecular structure of the compound: c-Myc Peptide1203.3Pricing
BP-50324MOCAc-PLGL(Dpa)ARMolecular structure of the compound: MOCAc-PLGL(Dpa)AR1093.2Pricing
BP-50308iRGD peptideMolecular structure of the compound: iRGD peptide948.1Pricing
BP-50405LyP-1, Peptide 1Molecular structure of the compound: LyP-1, Peptide 1992.2Pricing
BP-50306Peptide R, TFA saltMolecular structure of the compound: Peptide R, TFA salt900.1Pricing
BP-43730LanreotideMolecular structure of the compound: Lanreotide1096.398%Pricing
BP-43731Lanreotide acetateMolecular structure of the compound: Lanreotide acetate1096.395%Pricing
BP-43737EdotreotideMolecular structure of the compound: Edotreotide1421.798%Pricing
BP-50422OxytocinMolecular structure of the compound: Oxytocin1007.2Pricing
BP-50400[Asp371]-Tyrosinase (369-377), humanMolecular structure of the compound: [Asp371]-Tyrosinase (369-377), human1031.2Pricing
BP-50386Gp100 (25-33), humanMolecular structure of the compound: Gp100 (25-33), human1155.3Pricing
BP-50316MAGE-A1-derived peptide, acetate Molecular structure of the compound: MAGE-A1-derived peptide, acetate 1090.4Pricing
BP-50396d-(KLAKLAK)2, Proapoptotic PeptideMolecular structure of the compound: d-(KLAKLAK)2, Proapoptotic Peptide1495Pricing
BP-50309SVS-1 peptide acetateMolecular structure of the compound: SVS-1 peptide acetate2031.7Pricing
BP-50307Peptide 74Molecular structure of the compound: Peptide 741558.8Pricing
BP-50313DAPK substrate peptide Molecular structure of the compound: DAPK substrate peptide 1578.9Pricing
BP-50328[Lys3]-BombesinMolecular structure of the compound: [Lys3]-Bombesin1591.9Pricing
BP-50322BombesinMolecular structure of the compound: Bombesin1619.9Pricing
BP-50351Keap1-Nrf2-IN-16Molecular structure of the compound: Keap1-Nrf2-IN-161631.8Pricing
BP-50326NFF-3Molecular structure of the compound: NFF-31675.9Pricing
BP-50397Cathepsin D and E FRET SubstrateMolecular structure of the compound: Cathepsin D and E FRET Substrate1756.1Pricing
BP-503425-FAM-PMDM6Molecular structure of the compound: 5-FAM-PMDM61784.3Pricing
BP-50341Human PD-L1 inhibitor IVMolecular structure of the compound: Human PD-L1 inhibitor IV1856.9Pricing
BP-50402HIF-1 alpha (556-574)Molecular structure of the compound: HIF-1 alpha (556-574)2256.6Pricing
BP-43738IFN-gamma AntagonistMolecular structure of the compound: IFN-gamma Antagonist2629.198%Pricing
BP-43729Thymosin Alpha 1Molecular structure of the compound: Thymosin Alpha 13108.395%Pricing
BP-50312C-Peptide 1 (rat) Molecular structure of the compound: C-Peptide 1 (rat) 3259.6Pricing
BP-50352Thrombospondin (TSP-1)-derived CD36 binding motifMolecular structure of the compound: Thrombospondin (TSP-1)-derived CD36 binding motif566.7Pricing
BP-50311Cyclic PSAP peptide Molecular structure of the compound: Cyclic PSAP peptide 639.8Pricing
BP-50417PlecanatideMolecular structure of the compound: Plecanatide1681.9Pricing
BP-50408AAP-HMolecular structure of the compound: AAP-H531.3Pricing
BP-50310RGD-targeted Proapoptotic PeptideMolecular structure of the compound: RGD-targeted Proapoptotic PeptidePricing
BP-50407NG2 ligand peptideMolecular structure of the compound: NG2 ligand peptide1016.2Pricing
BP-50353AH1 Sequence (6-14) murine leukemia virus MuLVMolecular structure of the compound: AH1 Sequence (6-14) murine leukemia virus MuLV1127.3Pricing
BP-50399MUC5AC, Analog 1Molecular structure of the compound: MUC5AC, Analog 11501.6Pricing
BP-50365MUC5AC-13Molecular structure of the compound: MUC5AC-131704.8Pricing
BP-50355Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeledMolecular structure of the compound: Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeledPricing
BP-50374(Z-AA)2Rh110Molecular structure of the compound: (Z-AA)2Rh110Pricing
BP-50401Bak BH3 (72-87)Molecular structure of the compound: Bak BH3 (72-87)1724.9Pricing
BP-50394p53 (17-26), FITC labeledMolecular structure of the compound: p53 (17-26), FITC labeled1753Pricing
BP-50359520 MMP FRET Substrate 1Molecular structure of the compound: 520 MMP FRET Substrate 1Pricing
BP-50376520 MMP FRET Substrate 3Molecular structure of the compound: 520 MMP FRET Substrate 3Pricing
BP-50358520 MMP FRET Substrate IVMolecular structure of the compound: 520 MMP FRET Substrate IVPricing
BP-50375520 MMP FRET Substrate 6Molecular structure of the compound: 520 MMP FRET Substrate 6885.6Pricing
BP-50389520 MMP FRET Substrate 7Molecular structure of the compound: 520 MMP FRET Substrate 7Pricing
BP-50377580 MMP FRET Substrate VIIIMolecular structure of the compound: 580 MMP FRET Substrate VIIIPricing
BP-50390520 MMP FRET Substrate 9Molecular structure of the compound: 520 MMP FRET Substrate 9Pricing
BP-50373520 MMP FRET Substrate 11Molecular structure of the compound: 520 MMP FRET Substrate 11458.6Pricing
BP-50381520 MMP FRET Substrate 12Molecular structure of the compound: 520 MMP FRET Substrate 121484.7Pricing
BP-50379520 MMP FRET Substrate 13Molecular structure of the compound: 520 MMP FRET Substrate 13Pricing
BP-50378520 MMP FRET Substrate 14Molecular structure of the compound: 520 MMP FRET Substrate 14Pricing
BP-50391520 MMP FRET Substrate 15Molecular structure of the compound: 520 MMP FRET Substrate 15Pricing
BP-50364Tumour-associated MUC1 epitopeMolecular structure of the compound: Tumour-associated MUC1 epitopePricing
BP-50354Bak BH3 (72-87), TAMRA-labeledMolecular structure of the compound: Bak BH3 (72-87), TAMRA-labeled2137.5Pricing
BP-50337Human PD-L1 inhibitor IMolecular structure of the compound: Human PD-L1 inhibitor I2350.6Pricing
BP-50338Human PD-L1 inhibitor II Molecular structure of the compound: Human PD-L1 inhibitor II 2219.5Pricing
BP-50315Antennapedia peptideMolecular structure of the compound: Antennapedia peptidePricing
BP-50357[Lys(Ac)382]-p53 (372-389), human, biotin labeledMolecular structure of the compound: [Lys(Ac)382]-p53 (372-389), human, biotin labeledPricing
BP-50318Gastrin Releasing Peptide, humanMolecular structure of the compound: Gastrin Releasing Peptide, human2859.4Pricing
BP-50348Bad BH3 (mouse)Molecular structure of the compound: Bad BH3 (mouse)3003.4Pricing
BP-50361BAD (103-127) (human)Molecular structure of the compound: BAD (103-127) (human)3103.5Pricing
BP-50370Calpastatin subdomain BMolecular structure of the compound: Calpastatin subdomain B3136.8Pricing
BP-50393Noxa BH3, Peptide 1Molecular structure of the compound: Noxa BH3, Peptide 13075.8Pricing
BP-50371BAD (103-127), human, FAM-labeledMolecular structure of the compound: BAD (103-127), human, FAM-labeled3461.8Pricing
BP-50356Noxa A BH3 peptide, cell permeableMolecular structure of the compound: Noxa A BH3 peptide, cell permeable3555.3Pricing
BP-50339Tat-beclin 1Molecular structure of the compound: Tat-beclin 13741.1Pricing
BP-50346Tat-Beclin-1 scrambledMolecular structure of the compound: Tat-Beclin-1 scrambled3741.1Pricing
BP-50314pH-Low insertion peptideMolecular structure of the compound: pH-Low insertion peptidePricing
BP-50380MUC1, mucin coreMolecular structure of the compound: MUC1, mucin corePricing
BP-50383PUMA BH3Molecular structure of the compound: PUMA BH32384.6Pricing
BP-50384Bax BH3 (55-74)Molecular structure of the compound: Bax BH3 (55-74)2267.6Pricing
BP-50385NY-ESO-1 (87-111)Molecular structure of the compound: NY-ESO-1 (87-111)2869.4Pricing
BP-50392Proapoptotic Peptide, (klaklak)2, 5-FAM-labeledMolecular structure of the compound: Proapoptotic Peptide, (klaklak)2, 5-FAM-labeledPricing
BP-50395Bim BH3, Peptide IIIMolecular structure of the compound: Bim BH3, Peptide III2444.8Pricing
BP-50387Bim BH3, Peptide IVMolecular structure of the compound: Bim BH3, Peptide IV3269.7Pricing
BP-50403Bid BH3-R8Molecular structure of the compound: Bid BH3-R83616.1Pricing
BP-50404Bid BH3 (80-99)Molecular structure of the compound: Bid BH3 (80-99)2668Pricing
BP-50406[Lys(Ac)382]-p53 (372-389), humanMolecular structure of the compound: [Lys(Ac)382]-p53 (372-389), humanPricing
BP-50409LVTX-8Molecular structure of the compound: LVTX-82847.7Pricing
BP-50410KT2Molecular structure of the compound: KT22432.3Pricing
BP-50411F3 peptideMolecular structure of the compound: F3 peptide3431Pricing
BP-50412TAT-327Molecular structure of the compound: TAT-3272498.1Pricing
BP-50497EnfuvirtideMolecular structure of the compound: Enfuvirtide4491.9Pricing
BP-50423TeriparatideMolecular structure of the compound: Teriparatide4117.7Pricing
Cardiovascular Disease
BP-50415EptifibatideMolecular structure of the compound: Eptifibatide832Pricing
BP-50419AtosibanMolecular structure of the compound: Atosiban994.2Pricing
BP-43734OctreotideMolecular structure of the compound: Octreotide1019.3Pricing
BP-43733Octreotide AcetateMolecular structure of the compound: Octreotide Acetate1019.3Pricing
BP-43726CaeruleinMolecular structure of the compound: Caerulein1352.498%Pricing
BP-43728Somatostatin 14Molecular structure of the compound: Somatostatin 141637.997%Pricing
BP-50416BivalirudinMolecular structure of the compound: Bivalirudin2180.3Pricing
Diabetes
BP-43668SemaglutideMolecular structure of the compound: Semaglutide4113.7Pricing
BP-43669Semaglutide Intermediated P29Molecular structure of the compound: Semaglutide Intermediated P293175.5Pricing
BP-44012HO-STE-GLU(AEEA-AEEA-OSU)-OHMolecular structure of the compound: HO-STE-GLU(AEEA-AEEA-OSU)-OH831Pricing
BP-43670RetatrutideMolecular structure of the compound: Retatrutide4731.5Pricing
BP-43671TirzepatideMolecular structure of the compound: Tirzepatide4813.6Pricing
BP-44014tBuO-Ara-Glu(AEEA-AEEA-OH)-OtBuMolecular structure of the compound: tBuO-Ara-Glu(AEEA-AEEA-OH)-OtBu874.2Pricing
BP-44013FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OHMolecular structure of the compound: FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OH1224.6Pricing
BP-44015Tirzepatide sidechainMolecular structure of the compound: Tirzepatide sidechain1224.6Pricing
BP-43727LiraglutideMolecular structure of the compound: Liraglutide3751.398%Pricing
Inmunology
BP-50425TeduglutideMolecular structure of the compound: Teduglutide3752.1Pricing
Metabolic Disease
BP-50449L-Alanyl-L-glutamineMolecular structure of the compound: L-Alanyl-L-glutamine217.2Pricing
BP-50445L-CarnosineMolecular structure of the compound: L-Carnosine226.2Pricing
BP-50440H-Ser-His-OHMolecular structure of the compound: H-Ser-His-OH242.2Pricing
BP-50455S-(2,4-Dinitrophenyl)glutathioneMolecular structure of the compound: S-(2,4-Dinitrophenyl)glutathione473.4Pricing
BP-50439Angiotensin II (5-8), humanMolecular structure of the compound: Angiotensin II (5-8), human512.6Pricing
BP-50448Myristoyl Tetrapeptide-12Molecular structure of the compound: Myristoyl Tetrapeptide-12625.9Pricing
BP-50442AT-1002Molecular structure of the compound: AT-1002707.9Pricing
BP-50432tcY-NH2Molecular structure of the compound: tcY-NH2739.9Pricing
BP-50452RelamorelinMolecular structure of the compound: Relamorelin791Pricing
BP-50434tcY-NH2 TFAMolecular structure of the compound: tcY-NH2 TFA739.9Pricing
BP-50436GLP-1 receptor agonist 14Molecular structure of the compound: GLP-1 receptor agonist 14881Pricing
BP-50428OrforglipronMolecular structure of the compound: Orforglipron883Pricing
BP-50305Insulin Beta Chain Peptide (15-23)Molecular structure of the compound: Insulin Beta Chain Peptide (15-23)1009.2Pricing
BP-50429Xenin-8 TFAMolecular structure of the compound: Xenin-8 TFA1046.3Pricing
BP-50437IGRP(206-214)Molecular structure of the compound: IGRP(206-214)1096.3Pricing
BP-50424SetmelanotideMolecular structure of the compound: Setmelanotide1117.3Pricing
BP-50435JB-1Molecular structure of the compound: JB-11249.5Pricing
BP-50304Oligopeptide-68Molecular structure of the compound: Oligopeptide-681410.5Pricing
BP-50443BPC 157 acetateMolecular structure of the compound: BPC 157 acetate1419.6Pricing
BP-50431Gamma-1-Melanocyte Stimulating Hormone (MSH), amideMolecular structure of the compound: Gamma-1-Melanocyte Stimulating Hormone (MSH), amide1512.8Pricing
BP-50433Alpha-MSHMolecular structure of the compound: Alpha-MSH1664.9Pricing
BP-50438GersizangitideMolecular structure of the compound: Gersizangitide2355.7Pricing
BP-50454BeinaglutideMolecular structure of the compound: Beinaglutide3298.7Pricing
BP-50303C-Type Natriuretic Peptide (CNP) (1-22), humanMolecular structure of the compound: C-Type Natriuretic Peptide (CNP) (1-22), human2197.6Pricing
BP-50301Prolactin-Releasing Peptide (12-31), ratMolecular structure of the compound: Prolactin-Releasing Peptide (12-31), rat2272.6Pricing
BP-50444Hepcidin-25 (human)Molecular structure of the compound: Hepcidin-25 (human)2789.4Pricing
BP-50426st-Ht31Molecular structure of the compound: st-Ht312798.3Pricing
BP-50302Atrial natriuretic peptide (3-28) (human)Molecular structure of the compound: Atrial natriuretic peptide (3-28) (human)2880.2Pricing
BP-50298Proinsulin C-peptide (human)Molecular structure of the compound: Proinsulin C-peptide (human)3020.3Pricing
BP-50447Taspoglutide acetateMolecular structure of the compound: Taspoglutide acetatePricing
BP-50427[Des-His1,Glu9]-Glucagon amideMolecular structure of the compound: [Des-His1,Glu9]-Glucagon amide3358.7Pricing
BP-50300Proinsulin C-Peptide (55-89), humanMolecular structure of the compound: Proinsulin C-Peptide (55-89), human3617Pricing
BP-50441Alpha-CGRP (mouse, rat)Molecular structure of the compound: Alpha-CGRP (mouse, rat)3806.3Pricing
BP-50453Amylin, amide, humanMolecular structure of the compound: Amylin, amide, human3903.3Pricing
BP-50457PramlintideMolecular structure of the compound: Pramlintide3949.4Pricing
BP-50296Peptide YY (PYY) (3-36), HumanMolecular structure of the compound: Peptide YY (PYY) (3-36), Human4049.5Pricing
BP-50297Peptide YY (PYY), humanMolecular structure of the compound: Peptide YY (PYY), human4309.8Pricing
BP-50456a1-39-Corticotropin (human)Molecular structure of the compound: a1-39-Corticotropin (human)4541.1Pricing
BP-50446MazdutideMolecular structure of the compound: Mazdutide4563.1Pricing
BP-50299Gastric inhibitory polypeptide (human)Molecular structure of the compound: Gastric inhibitory polypeptide (human)4983.6Pricing
BP-50451EchistatinMolecular structure of the compound: Echistatin5417Pricing
BP-50450Insulin (human)Molecular structure of the compound: Insulin (human)Pricing
Neurological Disease
BP-50420DifelikefalinMolecular structure of the compound: Difelikefalin679.9Pricing
BP-43736Neurokinin BMolecular structure of the compound: Neurokinin B1210.595%Pricing
BP-50413Cetrorelix acetateMolecular structure of the compound: Cetrorelix acetate1431.1Pricing
BP-43732NeurotensinMolecular structure of the compound: Neurotensin167397%Pricing
BP-43735Neuropeptide SMolecular structure of the compound: Neuropeptide S2187.598%Pricing
BP-50418ZiconotideMolecular structure of the compound: Ziconotide2639.1Pricing
BP-50496NesiritideMolecular structure of the compound: Nesiritide3464Pricing
Fluorescent peptides
BP-43739Ac-Arg-Gly-Lys(Ac)-AMCMolecular structure of the compound: Ac-Arg-Gly-Lys(Ac)-AMC600.798%Pricing
Others
BP-50414Desmopressin Acetate trihydrateMolecular structure of the compound: Desmopressin Acetate trihydrate1069.2Pricing
BP-50421PegcetacoplanMolecular structure of the compound: Pegcetacoplan592.8Pricing
Radionuclide-Drug Conjugates
BP-50495DotatateMolecular structure of the compound: Dotatate1435.7Pricing